DMAC Past Earnings image   This DMAC past earnings page last updated 8/12/2022
DMAC Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/10/2022-0.130
Q1 20225/4/2022-0.130
Q4 20213/14/2022-0.100
Q3 202111/10/2021-0.180
Q2 20218/11/2021-0.170
Q1 20215/5/2021-0.190
Q4 20203/10/2021-0.230
Q3 202011/4/2020-0.190
Q2 20208/11/2020-0.170
Q1 20205/13/2020-0.190
Q4 20193/23/2020-0.210
Q3 201911/13/2019-0.200
Q2 20198/13/2019-0.210
Q1 20195/13/2019-0.270
DMAC Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/10/2022NA
Q1 20225/4/2022NA
Q4 20213/14/2022NA
Q3 202111/10/2021NA
Q2 20218/11/2021NA
Q1 20215/5/2021NA
Q4 20203/10/2021NA
Q3 202011/4/2020NA
Q2 20208/11/2020NA
Q1 20205/13/2020NA
Q4 20193/23/2020NA
Q3 201911/13/2019NA
Q2 20198/13/2019NA
Q1 20195/13/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree DMAC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
DiaMedica Therapeutics (DMAC) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DNA Past Earnings
DOOR Past Earnings
DSEY Past Earnings
EFTR Past Earnings
ELMS Past Earnings
ENJY Past Earnings
ENSC Past Earnings
ENVX Past Earnings
EPSN Past Earnings
ESNT Past Earnings

DMAC Past Earnings Q&A

What was the best and worst DMAC past earnings results?
For DiaMedica Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest DMAC past earnings result in our data set was -0.100/share posted in Q4 2021, while the lowest was in Q1 2019 when DMAC posted -0.270/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when DMAC reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 14 DMAC past earnings results in our data set.

On this page we presented the DMAC past earnings date information for DiaMedica Therapeutics. Reviewing that DMAC Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when DMAC posted gaap of -0.100/share. Meanwhile the lowest DMAC past earnings result was in Q1 2019, when DMAC posted gaap of -0.270/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when DMAC reported NA in revenue, while the smallest revenue quarter was Q2 2022 when DMAC reported NA in revenue.

Any self directed investor doing their due diligence on DMAC or any other given stock can benefit from researching all of the DiaMedica Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate DiaMedica Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for DMAC. Thanks for visiting, and the next time you need to research DMAC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: CHWA market cap history, POW Historical Stock Prices, WDNA market cap history.

 

DMAC Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.